Clinical Trials Browser

Phase 2 × Dermatitis, Atopic × Broncho-Vaxom × Clear all

NCT05222516 2023-08-08

Immunomodulation by OM-85 (Broncho-Vaxom) in Early AD

Phase 2 Terminated

Dermatitis, Atopic, Lymphoma, Follicular